Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo.
Zhou N, Cui Y, Zhu R, Kuang Y, Ma W, Hou J, Zhu Y, Chen S, Xu X, Tan K, Cao P, Duan X, Fan Y.
Zhou N, et al. Among authors: xu x.
Gynecol Oncol. 2022 Jul;166(1):126-137. doi: 10.1016/j.ygyno.2022.05.006. Epub 2022 Jun 7.
Gynecol Oncol. 2022.
PMID: 35688655